The U.S. Food and Drug Administration (FDA) has approved Gazyva® (obinutuzumab), developed by Genentech, as a treatment for adults with lupus nephritis (LN), also known as lupus-related kidney disease ...
SHELTON, CT / ACCESS Newswire / October 20, 2025 / NanoViricides, Inc., a publicly traded company (NYSE American:NNVC) (the "Company"), announced that its clinical lead drug NV-387 has shown strong ...
Amazon S3 on MSN
The Crime You Didn't Know Bruno Mars Committed
Bruno Mars has been dominating the charts since the release of his breakout album "Doo-Wops & Hooligans." Immediately, the ...
Amazon S3 on MSN
Is It Autism or OCD? Experts Say We May Be Getting It Wrong
Are we misdiagnosing autism? The number of children diagnosed with Autism Spectrum Disorder has skyrocketed in recent years — ...
The FDA has accepted Pharming Group’s supplemental new drug application for leniolisib in treating activated phosphoinositide ...
Sanofi's Tzield accepted for expedited review in the US for stage 3 type 1 diabetes through FDA Commissioner's National Priority Voucher pilot program If approved, Tzield would be the first disease-mo ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback